Is oral mucositis an inevitable consequence of intensive therapy for hematologic cancers?

作者信息

Sonis Stephen T

机构信息

Brigham and Women's Hospital, Boston, MA 02115, USA.

出版信息

Nat Clin Pract Oncol. 2005 Mar;2(3):134-5. doi: 10.1038/ncponc0104.

DOI:10.1038/ncponc0104

PMID:16264905

Abstract

摘要

相似文献

Is oral mucositis an inevitable consequence of intensive therapy for hematologic cancers?

Nat Clin Pract Oncol. 2005 Mar;2(3):134-5. doi: 10.1038/ncponc0104.

Palifermin for oral mucositis after intensive therapy for hematologic cancers.

N Engl J Med. 2004 Dec 16;351(25):2590-8. doi: 10.1056/NEJMoa040125.

Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.

J Clin Oncol. 2006 Nov 20;24(33):5186-93. doi: 10.1200/JCO.2005.02.8340. Epub 2006 Jan 3.

Palifermin (Kepivance) for myelotoxic-therapy-related mucositis.

Med Lett Drugs Ther. 2005 Apr 25;47(1207):36.

Misoprostol prophylaxis for high-dose chemotherapy-induced mucositis: a randomized double-blind study.

Bone Marrow Transplant. 1996 May;17(5):809-12.

Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation.

Clin Cancer Res. 2004 Dec 15;10(24):8318-24. doi: 10.1158/1078-0432.CCR-04-1118.

Palifermin and chemotherapy-induced oral mucositis.

N Engl J Med. 2005 Mar 24;352(12):1264-5; author reply 1264-5.

Effects of benzydamine on the oral mucositis during antineoplastic radiotherapy and/or intra-arterial chemotherapy.

Int J Tissue React. 1987;9(2):115-9.

Palifermin and chemotherapy-induced oral mucositis.

N Engl J Med. 2005 Mar 24;352(12):1264-5; author reply 1264-5.

Oral mucositis--the search for a solution.

N Engl J Med. 2004 Dec 16;351(25):2649-51. doi: 10.1056/NEJMe048239.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验